Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease
Authors
Keywords
-
Journal
International Forum of Allergy & Rhinology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-29
DOI
10.1002/alr.22202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of acquired mucociliary clearance defects using micro-optical coherence tomography
- (2017) Kiranya E. Tipirneni et al. International Forum of Allergy & Rhinology
- Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis — Results of a multicenter, prospective, randomized, double-blind, controlled trial
- (2016) Jochen G. Mainz et al. Journal of Cystic Fibrosis
- Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency
- (2015) Bradford A. Woodworth LARYNGOSCOPE
- Chlorogenic Acid Activates CFTR-Mediated Cl– Secretion in Mice and Humans
- (2015) Elisa A. Illing et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Sinupret Activates CFTR and TMEM16A-Dependent Transepithelial Chloride Transport and Improves Indicators of Mucociliary Clearance
- (2014) Shaoyan Zhang et al. PLoS One
- Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis
- (2014) Nichole Dean et al. International Forum of Allergy & Rhinology
- Comparison of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Ciliary Beat Frequency Activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in Primary Sinonasal Epithelial Cultures
- (2014) Bryant T. Conger et al. JAMA Otolaryngology-Head & Neck Surgery
- Curcumin and Genistein: the Combined Effects on Disease-associated CFTR Mutants and their Clinical Implications
- (2013) Yoshiro Sohma et al. CURRENT PHARMACEUTICAL DESIGN
- Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability
- (2013) Shaoyan Zhang et al. PLoS One
- Extensive Surgical and Comprehensive Postoperative Medical Management for Cystic Fibrosis Chronic Rhinosinusitis
- (2012) Frank W. Virgin et al. American Journal of Rhinology & Allergy
- Curcumin and genistein additively potentiate G551D-CFTR
- (2011) Ying-Chun Yu et al. Journal of Cystic Fibrosis
- Comparison of Vectorial Ion Transport in Primary Murine Airway and human Sinonasal Air-Liquid Interface Cultures, Models for Studies of Cystic Fibrosis, and other Airway Diseases
- (2010) Shaoyan Zhang et al. American Journal of Rhinology & Allergy
- Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial
- (2010) Jochen G. Mainz et al. AURIS NASUS LARYNX
- Exposure to cigarette smoke condensate reduces calcium activated chloride channel transport in primary sinonasal epithelial cultures
- (2010) Frank W. Virgin et al. LARYNGOSCOPE
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cigarette smoke condensate inhibits transepithelial chloride transport and ciliary beat frequency
- (2009) Noam A. Cohen et al. LARYNGOSCOPE
- Chloride channels as drug targets
- (2009) Alan S. Verkman et al. NATURE REVIEWS DRUG DISCOVERY
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started